General Information of the Compound
| Compound ID |
CP0377141
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
C-(5H-Dibenzo[a,d]cyclohepten-5-yl)-methylamine
Show/Hide
|
||||||||||||||||||
| Synonyms |
5-aminomethyl-5H-dibenzo[a,d]cycloheptene
5H-Dibenzo[a,d]cycloheptene-5-methanamine
AC1L4MLR
BDBM50097217
BKZVRYQHIBSITO-UHFFFAOYSA-N
C-(5H-Dibenzo[a,d]cyclohepten-5-yl)-methylamine
CHEMBL46619
CTK7E4003
SCHEMBL11335219
ZINC3622666
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H15N
|
||||||||||||||||||
| Molecular Weight |
221.303
|
||||||||||||||||||
| Canonical SMILES |
NCC1c2ccccc2C=Cc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H15N/c17-11-16-14-7-3-1-5-12(14)9-10-13-6-2-4-8-15(13)16/h1-10,16H,11,17H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
BKZVRYQHIBSITO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01492, 5-hydroxytryptamine receptor 2A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Clinical Information about the Compound